Literature DB >> 14630084

PU.1 supports proliferation of immature erythroid progenitors.

Robert C Fisher1, William B Slayton, Christopher Chien, Steven M Guthrie, Christopher Bray, Edward W Scott.   

Abstract

Despite normal levels of erythropoiesis in PU.1(-/-) embryos, PU.1(-/-) fetal hematopoietic progenitors are unable to establish sustained erythropoiesis in the adult bone marrow. This study demonstrates that PU.1(-/-) fetal erythroid progenitors are synergistically expanded by TPO plus SCF, but not combinations of EPO plus SCF, IL-3 or GM-CSF. The EPO defect is not corrected by a constitutively active variant of EPOR. Microarray analysis identified several candidate PU.1 target genes known to affect cytokine signaling and gene regulation in the erythroid lineage. These data suggest that PU.1 plays an important role in regulating the proliferation of immature erythroid progenitors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14630084     DOI: 10.1016/s0145-2126(03)00178-4

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  13 in total

1.  Inactivation of PU.1 in adult mice leads to the development of myeloid leukemia.

Authors:  Donald Metcalf; Aleksandar Dakic; Sandra Mifsud; Ladina Di Rago; Li Wu; Stephen Nutt
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

2.  Erythroblast transformation by the friend spleen focus-forming virus is associated with a block in erythropoietin-induced STAT1 phosphorylation and DNA binding and correlates with high expression of the hematopoietic phosphatase SHP-1.

Authors:  Kazuo Nishigaki; Charlotte Hanson; Takashi Ohashi; Angelo Spadaccini; Sandra Ruscetti
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

Review 3.  Characterization, regulation, and targeting of erythroid progenitors in normal and disordered human erythropoiesis.

Authors:  Brian M Dulmovits; Jimmy Hom; Anupama Narla; Narla Mohandas; Lionel Blanc
Journal:  Curr Opin Hematol       Date:  2017-05       Impact factor: 3.284

4.  PU.1 directly regulates cdk6 gene expression, linking the cell proliferation and differentiation programs in erythroid cells.

Authors:  Kevin S Choe; Olga Ujhelly; Sandeep N Wontakal; Arthur I Skoultchi
Journal:  J Biol Chem       Date:  2009-12-02       Impact factor: 5.157

5.  Mice lacking asparaginyl endopeptidase develop disorders resembling hemophagocytic syndrome.

Authors:  Chi-Bun Chan; Michiyo Abe; Noriyoshi Hashimoto; Chunhai Hao; Ifor R Williams; Xia Liu; Shinji Nakao; Akitsugu Yamamoto; Chengyun Zheng; Jan-Inge Henter; Marie Meeths; Magnus Nordenskjold; Shi-Yong Li; Ikuko Hara-Nishimura; Masahide Asano; Keqiang Ye
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-23       Impact factor: 11.205

6.  JAK2 V617F-dependent upregulation of PU.1 expression in the peripheral blood of myeloproliferative neoplasm patients.

Authors:  Tamotsu Irino; Munehiro Uemura; Humitsugu Yamane; Shigeto Umemura; Takahiko Utsumi; Naoki Kakazu; Taku Shirakawa; Mitsuhiro Ito; Takayo Suzuki; Kazuo Kinoshita
Journal:  PLoS One       Date:  2011-07-18       Impact factor: 3.240

7.  Friend Spleen Focus-Forming Virus Activates the Tyrosine Kinase sf-Stk and the Transcription Factor PU.1 to Cause a Multi-Stage Erythroleukemia in Mice.

Authors:  Joan Cmarik; Sandra Ruscetti
Journal:  Viruses       Date:  2010-10-11       Impact factor: 5.818

8.  Dynamic regulation of PU.1 expression in multipotent hematopoietic progenitors.

Authors:  Stephen L Nutt; Donald Metcalf; Angela D'Amico; Matthew Polli; Li Wu
Journal:  J Exp Med       Date:  2005-01-17       Impact factor: 14.307

9.  PU.1 regulates the commitment of adult hematopoietic progenitors and restricts granulopoiesis.

Authors:  Aleksandar Dakic; Donald Metcalf; Ladina Di Rago; Sandra Mifsud; Li Wu; Stephen L Nutt
Journal:  J Exp Med       Date:  2005-05-02       Impact factor: 14.307

10.  Sustained PU.1 levels balance cell-cycle regulators to prevent exhaustion of adult hematopoietic stem cells.

Authors:  Philipp B Staber; Pu Zhang; Min Ye; Robert S Welner; César Nombela-Arrieta; Christian Bach; Marc Kerenyi; Boris A Bartholdy; Hong Zhang; Meritxell Alberich-Jordà; Sanghoon Lee; Henry Yang; Felicia Ng; Junyan Zhang; Mathias Leddin; Leslie E Silberstein; Gerald Hoefler; Stuart H Orkin; Berthold Göttgens; Frank Rosenbauer; Gang Huang; Daniel G Tenen
Journal:  Mol Cell       Date:  2013-02-08       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.